VivoSeq
Other

Electroencephalography

0

Pipeline Programs↗

0

Active Trials↗

2

Companies Involved↗

Electroencephalography is an early-stage landscape with 0 programs across 2 companies. The most active players are Lundbeck, Syndeio Biosciences, Inc.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Lundbeck logo

Lundbeck

0 programs

PreclinicalS

Syndeio Biosciences, Inc

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Completed4 · 50%
Unknown status3 · 38%
Terminated1 · 13%

Clinical Trials

Trial Activity

8 trials

Acute Effect of Three Neuroactive Drugs Measured by Magnetoencephalography (MEG), Electroencephalography (EEG) and the Synchronous Neural Interaction Test
Completed·OOrasi Medical, Inc.·N/A·NCT00972985·15 enrolled
Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects
Completed·Lundbeck logoLundbeck·Phase 1·NCT02072278·32 enrolled
Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers
Completed·SSyndeio Biosciences, Inc·Phase 1·NCT05597241·40 enrolled
Electroencephalography (EEG) Biomarkers of Response in Depression
Completed·UUniversity of California, Los Angeles·Phase 4·NCT00759122·44 enrolled
Cannabis Effects on Electroencephalography
Terminated·PParc de Salut Mar·Phase 1·NCT04316598·16 enrolled
Electroencephalography (EEG) Signal Processing
Unknown status·SSt. Joseph's Healthcare Hamilton·N/A·NCT01369290·150 enrolled
Acute Effect of Lorazepam on Brain Activity Measured by Magnetoencephalograpy (MEG) and Electroencephalography (EEG)
Unknown status·OOrasi Medical, Inc.·N/A·NCT01272778·16 enrolled
Effect of Etomidate and Propofol on Electroencephalography
Unknown status·—·N/A·NCT04369014·68 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)